Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,183 recruiting studies in this area right now.
By phase
- Not applicable2,938
- Phase 2753
- Phase 1536
- Phase 3384
- Phase 1/Phase 2296
- Phase 4212
- Phase 2/Phase 364
Top conditions
- Breast Cancer1,227
- Melanoma183
- Rheumatoid Arthritis140
- Metastatic Breast Cancer138
- Atopic Dermatitis129
- Systemic Lupus Erythematosus125
- Breast Neoplasms120
- Triple Negative Breast Cancer117
- Colorectal Cancer91
- Ovarian Cancer90
- Psoriasis88
- Breast Carcinoma82
- Lung Cancer77
- Prostate Cancer70
- Rheumatoid Arthritis (RA)66
- Diabetic Foot Ulcer61
- Systemic Sclerosis60
- Cancer58
Leading sponsors
- Fudan University66
- M.D. Anderson Cancer Center52
- Memorial Sloan Kettering Cancer Center50
- Novartis Pharmaceuticals46
- Assistance Publique - Hôpitaux de Paris41
- Mayo Clinic41
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37
- AstraZeneca36
- National Cancer Institute (NCI)35
- Second Affiliated Hospital, School of Medicine, Zhejiang University30
Where studies are running
- California421
- Arizona159
- Florida132
- Alabama125
- New York109
- Texas107
- Massachusetts93
- Maryland91
- Pennsylvania74
- North Carolina68
Recruiting studies5,183 total
- NCT07005479Recruiting
Long-term lupus study at Peking University Hospital
This study looks at the long-term health of people with lupus. It aims to understand how the disease progresses over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07006649Recruiting
Study of blood flow in the eye for pseudoxanthoma elasticum
This study looks at blood flow in a layer of the eye called the choriocapillaris in people with pseudoxanthoma elasticum (PXE). It compares these findings with healthy volunteers to understand eye changes before they become severe.
AngersAges 18 years+ - NCT07007078RecruitingEarly Phase 1
Dihydroartemisinin for acne vulgaris
This study tests if a medicine called dihydroartemisinin (a type of artemisinin, often used for malaria) can help treat acne when applied to the skin. It's a small early-phase trial for people with acne vulgaris.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07007169RecruitingPhase 2
Mediterranean diet study for early breast cancer
This trial tests whether eating a Mediterranean-style diet (rich in vegetables, fruits, whole grains, and healthy fats) can help improve outcomes for women with early breast cancer who are receiving chemotherapy. You will be asked to follow this diet and keep a food diary using an online tool.
EsbjergAges 18 years+ - NCT07008339Recruiting
Nipple reconstruction using hyaluronic acid injections
This study tests if injecting a gel-like substance (hyaluronic acid) can improve nipple reconstruction in women who have had mastectomies. It aims to see if this method works better than or alongside tattoos for rebuilding the nipple-areola area.
Badalona, BarcelonaAges 18 years+ - NCT07008976RecruitingPhase 3
Testing TQB2102 versus standard treatment for HER2-positive advanced breast cancer
This trial tests a new drug called TQB2102 against a standard treatment (Kadcyla) for people with HER2-positive breast cancer that has spread or cannot be removed. It is for those whose cancer has worsened after previous HER2-targeted therapy.
Bengbu, AnhuiAges 18–75 - NCT07009093Recruiting
Mobile app for young women with breast cancer
This study tests a mobile app called Mighty Pro to help young women with breast cancer manage stress. It is for women ages 18–45 who are patients at a specific cancer center and feel some distress.
Charlotte, North CarolinaAges 18–45 - NCT07010484Recruiting
New imaging tests for polymyalgia rheumatica
This trial tests if new imaging methods can help diagnose and treat polymyalgia rheumatica (PMR). It may be for you if you're over 50, have pain in your shoulders or hips, and haven't taken steroids for PMR in the last 2 months.
AarhusAges 50 years+ - NCT07010692RecruitingPhase 1/Phase 2
Treating skin cancers with laser and ointment
This trial tests a combination of fractional laser and tirbanibulin ointment to treat basal or squamous cell skin cancer that hasn't been treated before. It may offer a less invasive option for people with these common skin cancers.
New York, New YorkAges 18 years+ - NCT07010835RecruitingPhase 1/Phase 2
Study of YK012 for moderate to severe lupus
This trial tests a new drug, YK012, for people with moderate to severe lupus. It aims to see if the drug can reduce disease activity and improve symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT07010900Recruiting
Cord blood plasma injections plus stretching for Peyronie's disease
This study tests if injections of platelet-rich plasma from cord blood, combined with daily penis stretching, works better than stretching alone to treat Peyronie's disease (curved erections). It may help men with moderate to severe curvature who haven't had prior treatment.
MilanAges 18–75 - NCT07010939Recruiting
Side effects and quality of life after breast cancer treatment in China
This study looks at how local treatments like surgery, chemotherapy, radiation, hormone therapy, or targeted therapy affect your side effects and quality of life. Researchers want to learn from women with early-stage breast cancer to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07011043RecruitingPhase 1
Study of budoprutug for lupus
This trial tests an investigational drug called budoprutug for people with active systemic lupus erythematosus (SLE) that has not improved after at least two previous treatments. The goal is to see if it can help control lupus symptoms.
Allen, TexasAges 18–65 - NCT07011654RecruitingPhase 1/Phase 2
Study of two drugs for metastatic triple-negative breast cancer
This trial tests a combination of two drugs, naxitamab and sacituzumab govitecan, for people with metastatic triple-negative breast cancer that has already been treated with at least one chemotherapy. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Houston, TexasAges 18 years+ - NCT07011979Recruiting
IBD study for those at higher risk
This study watches people who might be more likely to get Inflammatory Bowel Disease (IBD). It looks at close family members of IBD patients, people with autoimmune diseases, and those with certain digestive issues who also have a specific blood marker (ASCA). The goal is to find early signs and possibly prevent the disease.
SeoulAges 10 years+ - NCT07012486RecruitingEarly Phase 1
Dihydroartemisinin for female hair loss
This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT07012720Recruiting
Comparing breast cancer treatments before surgery
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
Xi'an, ShaanxiAges 25–75 - NCT07013097RecruitingPhase 1
Testing PG-033 in healthy adults: a first-in-human study
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
Beijing, Beijing MunicipalityAges 18–45 - NCT07013110RecruitingPhase 2
AI-guided precision therapy for active rheumatoid arthritis
This study tests a new, AI-powered treatment approach for rheumatoid arthritis. It's for people with active disease who haven't used certain biologic or targeted therapies in the last 6 months.
SingaporeAges 21 years+ - NCT07014007Recruiting
Testing a new moisturizer for eczema in different age groups
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
Quatre Bornes, MauritiusAges 3 months+ - NCT07014410RecruitingPhase 2
Pyrotinib, dalpiciclib, and letrozole for advanced breast cancer
This trial tests a combination of three targeted drugs for a type of advanced breast cancer that is both ER-positive and HER2-positive. The goal is to see if adding these two new drugs to standard hormone therapy can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–75 - NCT07014618Recruiting
Study to help breast and prostate cancer patients finish radiation therapy
This study tests whether a navigator program helps people from certain backgrounds complete their radiation therapy. If you have breast or prostate cancer and are scheduled for radiation, you may be able to join.
Oklahoma City, OklahomaAges 18 years+ - NCT07014787Recruiting
Balance and knee cartilage study
This study looks at how different stages of knee cartilage damage (chondromalacia) affect your balance. You will be tested on a special balance machine to help doctors understand how your knee problem might affect your stability.
GizaAges 18–40 - NCT07015073Recruiting
Comparing laser combinations for port-wine stains
This trial tests whether using two different lasers one after the other works better than a single laser for treating port-wine stains (a type of birthmark). The goal is to see if the combination treatment can improve appearance with fewer sessions.
Madrid, SpainAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,183 recruiting dermatology studies from the U.S. registry right now, out of 8,336 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.